IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Lonza Licenses Biotech to Roche

10:22 AM MDT | July 30, 2007 | Chemical Week Editorial Staff

Lonza says it has agreed to license its glutamine synthetase (GS) expression system and GS-CHO protein free system to Roche for the manufacture of therapeutic recombinant proteins and monoclonal antibodies. Financial terms were not disclosed. The agreement builds on a supply agreement between Lonza and Roche for undisclosed...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa